3 stories mentioning HKG:6132Updated just now
Every FINWIRES story that references HKG:6132, newest first.
HJ Science (HKG:6132) saw a tepid stock market debut as its shares opened flat on their maiden trading in Hong Kong Tuesday morning.The clinical-stage biotech company opened at HK$81.80 per share, unchanged from its IPO price.
HJ Science (HKG:6132) raised HK$1.02 billion in net proceeds from its initial public offering in Hong Kong, according to a Monday after-market filing with the Hong Kong Exchange.The clinical-stage biotech company priced its IPO at HK$81.80 per share, issuing 13.6 million shares in total.The Hong Kong public offering portion of the deal was 2,007.6 times subscribed, with a final allotment of 1.36 million shares.The international offering was 7 times subscribed, with 12.2 million shares allocated.Cornerstone investors received 6.2 million shares, representing 45.79% of the IPO shares.HJ Science is set to debut on the Hong Kong bourse today, June 23.
HJ Science (HKG:6132) launched its Hong Kong initial public offering on Friday, seeking to raise HK$1.11 billion.The Chinese biotechnology company is offering 13.6 million H shares at an indicative price of HK$81.80 per share, according to a Hong Kong bourse filing.The offering comprises around 1.4 million shares for Hong Kong investors and 12.2 million shares for international investors, subject to reallocation.The IPO's allocation results are due June 22, ahead of the company's planned trading debut on June 23.Net proceeds will be used primarily to advance the company's clinical research and development activities.The company secured six cornerstone investors, including Foresight Fund, that committed to subscribe to $65 million worth of IPO shares.Citic Securities is the sole coordinator of the IPO.
